Search research articles
Contact Us
Filters
Showing results (201-210 of 212) with videos related to
Page
of 22
Sort By:
The New England Journal of Medicine
|
June 2, 2015
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff, et al.
The New England Journal of Medicine
|
September 16, 2024
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D Wolchok, Vanna Chiarion-Sileni, Piotr Rutkowski, et al.
Nature Biotechnology
|
November 2, 2021
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
Diego Chowell, Seong-Keun Yoo, Cristina Valero, et al.
Nature
|
April 12, 2017
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C Huang, Michael A Postow, Robert J Orlowski, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study
Michael A Postow, Peter D Zang, Sumanta K Pal, et al.
The Lancet. Oncology
|
July 4, 2019
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Rodabe N Amaria, Alexander M Menzies, Elizabeth M Burton, et al.
Nature Methods
|
April 11, 2025
Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling
Alexandre Pellan Cheng, Adam J Widman, Anushri Arora, et al.
JCO Precision Oncology
|
September 12, 2017
OncoKB: A Precision Oncology Knowledge Base
Debyani Chakravarty, Jianjiong Gao, Sarah M Phillips, et al.
Nature Medicine
|
June 14, 2024
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
Adam J Widman, Minita Shah, Amanda Frydendahl, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 212) with videos related to
Sort By:
Page
of 22
The New England Journal of Medicine
|
June 2, 2015
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff, et al.
The New England Journal of Medicine
|
September 16, 2024
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D Wolchok, Vanna Chiarion-Sileni, Piotr Rutkowski, et al.
Nature Biotechnology
|
November 2, 2021
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
Diego Chowell, Seong-Keun Yoo, Cristina Valero, et al.
Nature
|
April 12, 2017
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C Huang, Michael A Postow, Robert J Orlowski, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study
Michael A Postow, Peter D Zang, Sumanta K Pal, et al.
The Lancet. Oncology
|
July 4, 2019
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Rodabe N Amaria, Alexander M Menzies, Elizabeth M Burton, et al.
Nature Methods
|
April 11, 2025
Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling
Alexandre Pellan Cheng, Adam J Widman, Anushri Arora, et al.
JCO Precision Oncology
|
September 12, 2017
OncoKB: A Precision Oncology Knowledge Base
Debyani Chakravarty, Jianjiong Gao, Sarah M Phillips, et al.
Nature Medicine
|
June 14, 2024
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
Adam J Widman, Minita Shah, Amanda Frydendahl, et al.
Page
of 22